Loading ...
Sorry, an error occurred while loading the content.

Altair Nano Breakthrough in Battery Materials

Expand Messages
  • RemyC
    From: http://www.marketwire.com/mw/release_html_b1?release_id=80729 via: http://www.ourmolecularfuture.com Altair Nanotechnologies Achieves Breakthrough in
    Message 1 of 1 , Feb 27, 2005
      via: http://www.ourmolecularfuture.com

      Altair Nanotechnologies Achieves Breakthrough in Battery Materials
      Altair's Developments Pave the Way for a New Generation of Rechargeable

      RENO, NV -- (MARKET WIRE) -- 02/10/2005 -- Altair Nanotechnologies, Inc.
      (NASDAQ: ALTI) announced today that it has achieved a breakthrough in
      Lithium Ion battery electrode materials, which will enable a new generation
      of rechargeable battery to be introduced into the marketplace, as well as
      create new markets for rechargeable batteries. These new materials allow
      rechargeable batteries to be manufactured that have three times the power of
      existing Lithium Ion batteries at the same price and with recharge times
      measured in a few minutes rather than hours.

      The technical achievements are being praised by the battery community as
      truly remarkable and will likely enable a new generation of rechargeable
      battery to be produced. Altair has confidentiality agreements in place with
      some of the world's leading battery development companies to evaluate and
      commercialize these battery electrode materials.

      Altair's research and development efforts were allowed two new patents
      (announced on January 7th and 14th, 2005) and a National Science Foundation
      grant was successfully completed in January, 2005, by Altair. New markets
      for fast charging batteries will include the handheld power tools market
      increasing the productivity of, for example, construction workers while
      lowering their overhead costs. Other markets include hybrid electric
      vehicles, portable electronics and medical surgery tools -- solving the
      problem of electrical wires all over the operating room floor.

      Endorsements for Altair's work in this area have come from many quarters.
      Two eminent experts in battery technology, Dr. K. M. Abraham and Dr.
      Vassilis G. Keramidas, have expressed strong support for Altair's work

      "The nanomaterials Altair is developing are the next generation of electrode
      materials for lithium-ion batteries and Altair's research and product
      development is laying the ground work for a new generation of ultra high
      power lithium ion batteries," commented Dr. K. M. Abraham. "A key
      requirement to the above applications is the ability to recharge the battery
      very quickly, for example in a few minutes. Current Li Ion batteries are
      incapable of such quick charge times because of the chemistry of the anode
      materials. Altair has found a solution to this with their nano-sized lithium
      titanium oxide."

      "Altair's nanomaterials, which have a virtually zero strain crystal lattice,
      eliminate the main cause for battery electrode material fatigue, which
      limits rechargeable battery life, increasing the number of recharge and
      discharge cycles from a few hundred to many thousand cycles," said Dr.
      Vassilis G. Keramidas. "I find Altair's development strategy and proposed
      research direction sound and a necessary step in establishing the Li-Ion
      electrochemistry as a viable contender for large battery applications."

      "Our research in battery electrode materials is a further indication of how
      Altair's scientists are able to apply their nanomaterials science knowledge
      to solving real world needs," commented Altair CEO Dr. Alan J. Gotcher.
      "Many of the technology and product development initiatives that we have
      been working on for the last few years are now coming to the
      commercialization stage. Each step is another validation of our business
      strategy and product technology platform. Altair's nanomaterial based, micro
      porous electrode technology has performance and stability advantages that
      appear to be unmatched when compared to the best commercialized technology
      in the market today."

      Dr. K. M. Abraham

      Dr. Abraham, the principal of E-KEM Sciences, has over 28 years of
      experience in lithium battery research and development. He has made
      pioneering contributions to the development of the rechargeable battery
      industry. Dr. Abraham has authored and co-authored over 150 publications and
      16 US patents in battery technology. He received his Ph. D. from Tufts
      University and conducted post-doctoral research at Vanderbilt University and
      MIT. In 2000 he was elected a Fellow of the Electrochemical Society. Dr
      Abraham is on Altair's Scientific Advisory Board.

      Dr. Vassilis G. Keramidas

      Dr. Keramidas, Managing Director of Keramidas International, provides
      management consulting to major corporations on the formulation and execution
      of their research and development. Prior to founding Keramidas
      International, he was Vice President of Applied Research at Telcordia
      Technologies (formerly Bellcore). His division at Telcordia made seminal
      contributions in the fields of photonic and electronic materials. The
      Bellcore research on energy storage ushered in the polymer battery Li-Ion
      technology with the invention of the Bellcore Plastic Li-Ion (PLiON)
      technology. Dr. Keramidas sits on the Board of two battery companies.


      Altair Nanotechnologies, through product innovation, is a leading supplier
      of advanced ceramic nanomaterial technology worldwide. Altair
      Nanotechnologies has assembled a unique team of material scientists who,
      coupled with collaborative ventures with industry partners and leading
      academic centers, has pioneered an impressive array of intellectual property
      and product achievements.

      Altair Nanotechnologies has developed robust proprietary technology
      platforms for manufacturing a variety of crystalline and non-crystalline
      nanomaterials of unique structure, performance, quality and cost. The
      company has a scalable manufacturing capability to meet emerging
      nanomaterials demands, with capacity today to produce hundreds of tons of

      The company is organized into two divisions: Life Sciences and Performance
      Materials. The Life Sciences Division is pursuing market applications in
      pharmaceuticals, drug delivery, dental materials, cosmetics and other
      medical markets. The Performance Materials Division is pursuing market
      applications in Advanced Materials for paints and coatings; titanium metal
      manufacturing, catalysts and water treatment; and alternative energy. For
      additional information on Altair and its nano-materials, visit

      AltairnanoT, Altair Nanotechnologies, Inc.®, Altair NanomaterialsT, TiNano®,
      RenaZorbT, NanoCheckT, TiNano SpheresT and the Hydrochloride Pigment
      ProcessT are trademarks or registered trademarks of Altair Nanotechnologies,

      Forward-Looking Statements

      This release may contain forward-looking statements as well as historical
      information. Forward-looking statements, which are included in accordance
      with the "safe harbor" provisions of the Private Securities Litigation
      Reform Act of 1995, may involve risks, uncertainties and other factors that
      may cause the company's actual results and performance in future periods to
      be materially different from any future results or performance suggested by
      the forward-looking statements in this release. These risks and
      uncertainties include, without limitation, the risks that Altair expenses
      will rise during the following quarters as a result of unexpected cash or
      non-cash expenses; Altair's numerous development stage products will not be
      developed to the point of commercialization or that, even if commercialized,
      no market will exist for such products or Altair will fail to effectively
      market to customers in a market: the risks that Altair will be unable to
      enter into license agreements regarding its pigment process (AHPP),
      RenaZorb, its TiNano Sphere or other developing products, that even if
      Altair enters into such license agreements, short term revenues from such
      agreements will not be sufficient to fund Altair's operations in the long
      run, and that animal testing or future testing of RenaZorb or other products
      of the company will not be successful and that development will need to be
      terminated. In general, Altair is, and expects to be in the immediate
      future, dependent upon funds generated from sales of securities, grants,
      testing agreements, and licensing agreements to fund its testing,
      development and ongoing operations. In addition, other risks are identified
      in the company's most recent Annual Report on Form 10-K, as filed with the
      SEC. Such forward-looking statements speak only as of the date of this
      release. The company expressly disclaims any obligation to update or revise
      any forward-looking statements found herein to reflect any changes in
      company expectations or results or any change in events.

      For Additional Information:
      Marty Tullio or Mark Tullio
      McCloud Communications, LLC
      marty@ mccloudcommunications.com
      mark@ mccloudcommunications.com

      SOURCE: Altair Nanotechnologies
    Your message has been successfully submitted and would be delivered to recipients shortly.